These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28903504)

  • 1. Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele.
    Hashem M; Jhaveri R; Saleh DA; Sharaf SA; El-Mougy F; Abdelsalam L; Shardell MD; El-Ghazaly H; El-Kamary SS
    Clin Infect Dis; 2017 Sep; 65(6):999-1005. PubMed ID: 28903504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children.
    Ruiz-Extremera A; Muñoz-Gámez JA; Salmerón-Ruiz MA; de Rueda PM; Quiles-Pérez R; Gila-Medina A; Casado J; Belén Martín A; Sanjuan-Nuñez L; Carazo A; Pavón EJ; Ocete-Hita E; León J; Salmerón J
    Hepatology; 2011 Jun; 53(6):1830-8. PubMed ID: 21413051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.
    Knapp S; Warshow U; Ho KM; Hegazy D; Little AM; Fowell A; Alexander G; Thursz M; Cramp M; Khakoo SI
    Gastroenterology; 2011 Jul; 141(1):320-5, 325.e1-2. PubMed ID: 21600205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.
    Abdelwahab SF; Zakaria Z; Allam WR; Hamdy S; Mahmoud MA; Sobhy M; Rewisha E; Waked I
    Arch Virol; 2015 Nov; 160(11):2833-7. PubMed ID: 26280523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients.
    Rosso C; Abate ML; Ciancio A; Strona S; Caviglia GP; Olivero A; Touscoz GA; Rizzetto M; Pellicano R; Smedile A
    World J Gastroenterol; 2014 Sep; 20(36):13146-52. PubMed ID: 25278709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
    Grebely J; Petoumenos K; Hellard M; Matthews GV; Suppiah V; Applegate T; Yeung B; Marks P; Rawlinson W; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ;
    Hepatology; 2010 Oct; 52(4):1216-24. PubMed ID: 20803561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3.
    Gupta AC; Trehanpati N; Sukriti S; Hissar S; Midha V; Sood A; Sarin SK
    J Med Virol; 2014 Apr; 86(4):707-12. PubMed ID: 24415442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients.
    Mangia A; Santoro R; Sarli R; Mottola L; Piazzolla V; Petruzzellis D; Bacca D; Clemente R; Copetti M; di Mauro L; Lotti G; Sacco M; Stefano I
    Antivir Ther; 2011; 16(8):1309-16. PubMed ID: 22155912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.
    El Awady MK; Bader El Din NG; Tabll A; El Hosary Y; Abdel Aziz AO; El Khayat H; Salama M; Abdelhafez TH
    World J Gastroenterol; 2013 Jan; 19(2):290-8. PubMed ID: 23345953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.
    Rao HY; Sun DG; Jiang D; Yang RF; Guo F; Wang JH; Liu F; Zhang HY; Zhang HH; Du SC; Jin Q; Qin H; Lok AS; Wei L
    J Viral Hepat; 2012 Mar; 19(3):173-81. PubMed ID: 22329371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.
    Labarga P; Soriano V; Caruz A; Poveda E; Di Lello FA; Hernandez-Quero J; Moreno S; Bernal E; Miró JM; Leal M; Gutierrez F; Portilla J; Pineda JA;
    AIDS; 2011 Mar; 25(6):761-6. PubMed ID: 21378537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphisms.
    Akkarathamrongsin S; Payungporn S; Thong VD; Poovorawan K; Prapunwattana P; Poovorawan Y; Tangkijvanich P
    World J Gastroenterol; 2014 Aug; 20(30):10599-605. PubMed ID: 25132781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.
    Derbala M; Rizk N; Shebl F; Alkaabi S; Eldweik N; John A; Sharma M; Yaqoob R; Almohanadi M; Butt M; Alejji K
    World J Gastroenterol; 2012 Dec; 18(47):7003-8. PubMed ID: 23323000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
    Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
    J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody-positive blood donors in China.
    Liu Y; Ma H; Chen S; Wang J; Liu G; Xu M; Ke L; He M
    Transfusion; 2013 Oct; 53(10 Pt 2):2498-504. PubMed ID: 23782163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance.
    Visco-Comandini U; Lapa D; Taibi C; Angeletti C; Capobianchi MR; Garbuglia AR
    Dig Liver Dis; 2014 Apr; 46(4):348-52. PubMed ID: 24387833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.
    Rallón NI; Soriano V; Naggie S; Restrepo C; Goldstein D; Vispo E; McHutchison J; Benito JM
    AIDS; 2011 May; 25(8):1025-33. PubMed ID: 21505315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of IL28B rs12979860 genotype and gender with spontaneous clearance of HCV infection: a Pakistani cross-section study.
    Ali Q; Jamal A; Imran M; Ullah S; Kalam I; Ullah S; Waqar AB
    Per Med; 2018 Nov; 15(6):495-502. PubMed ID: 30398404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
    Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
    Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: systematic review of its prevalence in chronic hepatitis C patients and general population frequency.
    Kaczor MP; Seczyńska M; Szczeklik W; Sanak M
    Pharmacol Rep; 2015 Apr; 67(2):260-6. PubMed ID: 25712648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.